AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will be presenting at the JPMorgan Healthcare Conference on Monday, January 12, 2004 at 10:00 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, California. Ginger L. Graham, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview and an update on recent company activities. This presentation will be webcast live by JPMorgan, and a recording will be made available following the presentation. The webcast and the recording will be accessible through Amylin's corporate website, located at http://www.amylin.com/ . To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright